Results 301 to 310 of about 254,031 (357)
Some of the next articles are maybe not open access.
Gastroenterology Clinics of North America, 1993
In summary, many new modalities of immunosuppression after transplantation are being investigated (Fig. 1). These approaches include various new drugs or monoclonal antibodies that target different cell subsets, cellular activation pathways, cellular effector function or mediators (such as cytokines) of effector function, ligands that stabilize ...
G L, Bumgardner, J P, Roberts
openaire +2 more sources
In summary, many new modalities of immunosuppression after transplantation are being investigated (Fig. 1). These approaches include various new drugs or monoclonal antibodies that target different cell subsets, cellular activation pathways, cellular effector function or mediators (such as cytokines) of effector function, ligands that stabilize ...
G L, Bumgardner, J P, Roberts
openaire +2 more sources
Immunosuppressive Agents in Dermatology
Dermatologic Clinics, 1993Azathioprine, cyclophosphamide, and cyclosporine are immunosuppressive agents commonly used by dermatologists. Azathioprine has a good safety profile and is preferred by most dermatologists for the treatment of bullous pemphigoid, cutaneous vasculitides, chronic eczematous dermatitides, and cutaneous manifestations of connective tissue diseases.
V C, Ho, D M, Zloty
openaire +2 more sources
IMMUNOSUPPRESSIVE AGENTS IN DERMATOLOGY
Dermatologic Clinics, 1998Azathioprine, cyclophosphamide, methotrexate, and cyclosporine are the immunosuppressive agents most commonly used by dermatologists. Azathioprine has a relatively good safety profile and is therefore often preferred for the treatment of chronic eczematous dermatitides and bullous disorders.
Vincent C. Ho, Jan P. Dutz
openaire +3 more sources
Immunosuppressive agents for myasthenia gravis
Cochrane Database of Systematic Reviews, 2005The benefits of different immunosuppressants for myasthenia gravis (MG) are unclear.Assessment of immunosuppressant drug efficacy in MG.We searched the Cochrane Neuromuscular Disease Group Trials Register, MEDLINE (from January 1966 to July 2007), EMBASE (from January 1980 to July 2007), review and trial bibliographies and contacted trial authors.Types
Tarek Sharshar +2 more
openaire +3 more sources
Immunosuppressive agents and asthma
Clinical Reviews in Allergy, 1994One of the goals of asthma therapy is to maintain control of symptoms without producing unwanted effects from asthma medications. Corticosteroids are the mainstay for intractable chronic asthma, but their long-term use in high doses is limited by the risk of significant adverse effects.
openaire +3 more sources
Glucocorticosteroids as immunosuppressive agents
Seminars in Veterinary Medicine and Surgery: Small Animal, 1997When administered at pharmacological dosages, glucocorticosteroid hormones alter leukocyte kinetics, phagocytic cell function, cell-mediated immunity, and, to a lesser extent, humoral immunity. These properties are used to advantage in the treatment of immunologically mediated disease.
openaire +2 more sources
Dermatologic Therapy With Immunosuppressive Agents
Postgraduate Medicine, 1975The use of powerful immunosuppressive agents such as methotrexate, cyclophosphamide, and azathioprine in the treatment of serious skin diseases is a relatively recent development whose efficacy is borne out in many studies. Using an immunosuppressant often makes possible an appreciable reduction in dosage of steroid necessary to control disease and, in
Robert I. Rudolph, James J. Leyden
openaire +3 more sources
Bacterial endotoxins as immunosuppressive agents
Experientia, 1971Der Adjuvanseffekt von bakteriellem Endotoxin gegenuber Schaferythrocyten war nicht nachweisbar, wenn Mause vor der primaren antigenen Stimulierung 9 Tage lang eine tagliche Injektion von 20 µg Endotoxin erhielten. Andererseits wurde unter diesen Bedingungen eine Primarreaktion gefunden, wie sie nach alleiniger Injektion des Erythrocytenantigens zur ...
H. Fresenius, M. Angerer, H. Finger
openaire +3 more sources
Neurologic Complications of Immunosuppressive Agents
Neurologic Clinics, 1988The immunosuppressive agents that are an integral part of organ transplantation serve to protect grafts from rejection as well as to prevent or treat GVHD. They include CsA, corticosteroids, OKT3 monoclonal antibody, HDARA-C, azathioprine, and ATG. Of these, all but azathioprine and ATG have direct neurologic complications that are due to the drugs ...
Russell W. Walker, Joel A. Brochstein
openaire +3 more sources
2001
In the 1990’s, many new small and large molecules have been discovered and developed for use as immunosuppressants in transplantation. This chapter focuses on those small molecules that have shown to have immunosuppressive activity in patients1,2 (Fig.1).
Tuija Ikonen +2 more
openaire +2 more sources
In the 1990’s, many new small and large molecules have been discovered and developed for use as immunosuppressants in transplantation. This chapter focuses on those small molecules that have shown to have immunosuppressive activity in patients1,2 (Fig.1).
Tuija Ikonen +2 more
openaire +2 more sources